PT Kimia Farma Sungwun Pharmacopia (KFSP) was established on January 25, 2016 and is the first pharmaceutical raw material factory in Indonesia. Scheme is a collaboration with a joint venture between PT Kimia Farma (Persero) Tbk and PT Sungwun Pharmacopia Indonesia as a representative of Sungwun Pharmacopia Co. Ltd. of South Korea. Shareholder composition, namely 75% of PT Kimia Farma (Persero) Tbk and 25% Sungwun Pharmacopia Co. Ltd

On October 10, 2016, has done groundbreaking by the Minister of Health, Head of the Indonesian Pom, Chairman of Commission IX of the House of Representatives, President Director Sungwung Pharmacopia, Co., Ltd. and President Commissioner of PT Kimia Farma (Persero) Tbk. as a sign of the commencement of the process of building a raw material plant for this drug

The purpose and objective of KFSP is to strive in the chemical industry, by establishing sustainable pharmaceutical raw material factories with initial products of medicinal raw materials and high function chemicals

Based in Lippo Cikarang, Bekasi, West Java, KFSP produce eight (8) items of raw materials, namely the active drug Simvastatin, Atorvastatin, Rosuvastatin, esomeprazole, Pantroprazole, rabeprazole, Clopidogrel and Sarpogrelate. In addition to producing the active pharmaceutical raw materials, the company also will produce seven (7) items high chemical function that is Lauoylysin, Argine Nitrate, Argine, ketoglutarate, Milk Thistle, Thiaminedilaurysulfate, Ceramide and 1.2-Henandiol used as raw materials for cosmetics and food supplement

Address:
Jl Angsana Raya Blok A06 - 001 Delta Silicon
Cikarang Industrial Estate - Bekasi

STOCK PRICE

grafik KAEF.JK
2.390 (+1,70%)
Prev Close : 2.350
Volume : 31.800
BPOMLogo Badan POM kemenbumnlogo Kementerian BUMN
Kemenkeslogo Kementerian Kesehatan beilogo PT. Bursa Efek Jakarta

CURRENCY RATES